| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
THOUSAND OAKS, Calif.—With $100 million in its coffers, Amgen Ventures, a corporate venture capital fund initiated by Amgen Inc. in late 2004, will provide monetary assistance for emerging biotechnology companies that work in Amgen's areas of interest related to human therapeutics.
 
The fund made its initial investment in Accelerator Corp., a Seattle-based biotechnology investment and development firm that has supported VieVax Corp. and VSLT Corp., which are doing work in vaccine platform technology and autoimmune and inflammatory diseases, respectively.
 
Christine Cassiano, senior manager, corporate communications for Amgen, says, "Amgen Ventures intends to target early-stage, science-driven companies with assets in appropriate therapeutic areas or with technologies of interest to Amgen" In the past, she said, Amgen's investments occurred through its licensing outreach progam "and were typically in companies that were in a later stage of their development. Amgen Ventures' investments are in companies that are in a stage of development that is not yet appropriate for that more traditional type of collaboration with Amgen."
 
Managing Director Jay Hagan is overseeing the venture capital fund, which is based in San Diego.
 
Cassiano said there is no timetable for investing the funds, nor will Amgen require a board seat with its investments.
 
"Each investment will be evaluated on its own merit and needs," explained Cassiano. "This decision as to whether or not someone from Amgen Ventures will sit on the board of the portfolio company will depend on the nature of the investment."

About the Author

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

GreenCooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue